June 20
7:10 am
—
7:55 am
This is a non-CME/CE presentation.
Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity
Sponsored by Axsome Therapeutics
June 20
12:50 pm
—
1:35 pm
This is a non-CME/CE presentation.
The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)
Sponsored by Otsuka Pharmaceuticals
Gerald Maguire, MD, DFAPA
This program provides an overview of the efficacy and safety profile of an adjunctive therapy for adult patients with major depressive disorder (MDD).
June 21
7:10 am
—
7:55 am
This is a non-CME/CE presentation.
UZEDY: An Innovative Delivery Platform Allows for Rapid Absorption and Sustained Release of Risperidone
Sponsored by Teva Pharmaceutical
Henry Narsallah, MD
This presentation explores the issues associated with relapse, partial adherence, and nonadherence in patients with schizophrenia; highlights treatment considerations and the role of LAIs in schizophrenia management; and discusses the key attributes, including efficacy, safety, and dosing, that make UZEDY a different treatment option for schizophrenia.
June 21
12:15 pm
—
1:15 pm
This is a non-CME/CE presentation.
Tardive Dyskinesia Is Personal: Go Beyond the Data With a Real Patient Story
Sponsored by Neurocrine Biosciences
Craig Chepke, MD, DFAPA
This program will communicate the burden and impact of tardive dyskinesia, review a patient’s experience with tardive dyskinesia and the impact it has had on their mental well-being, and discuss an FDA-approved treatment for adults with tardive dyskinesia.
June 22
7:10 am
—
7:55 am
This is a non-CME/CE presentation.
Moving Forward: Evolving Practices for Identifying, Assessing and Managing Tardive Dyskinesia Copy
Sponsored by Otsuka Pharmaceutical
Carrie Pettit, APRN, MSN, FNP-C & Tory Woodard, PMHNP-BC
June 22
12:35 pm
—
1:20 pm
This is a non-CME/CE presentation.
Moving Forward: Evolving Practices for Identifying, Assessing and Managing Tardive Dyskinesia
Sponsored by Teva Pharmaceutical
Leslie Citrome, MD, MPH
This comprehensive presentation discusses the impact of TD; screening, assessment, and diagnosis; and considerations for appropriate treatment, including the role of AUSTEDO XR. In this presentation, audiences will have the opportunity to explore key topics in more depth and practice their clinical skills.
June 20
9:40 am
—
10:40 am
Independent CME Sumposium
The Multiple Layers of MDD Management: Unraveling the Who, When, and How for Antidepressant Modification
Supported by and Independent Educational Grant from Axsome Therapeutics
Additional 1.00 hours of CME
June 21
9:25 am
—
10:25 am
Independent CME Symposium
Prescription Digital Therapeutics (PDTs): Paving the Path to Innovative Mental Health Solutions
Supported by and Independent Educational Grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Additional 1.00 hours of CME
Leslie Citrome, MD, MPH; Christoph U. Correll, MD; Lisa A. Marsch, MD
Join us for a symposium on prescription digital therapeutics in psychiatry designed to encourage the exchange of ideas between leaders in the field and attendees.